IISER Pune scientists uncover bacteria’s new survival secret

Pune:  A recent study at the Institute of Science Education and Research (IISER), Pune, found that Escherichia coli can quickly survive antibiotics by temporarily making extra copies of a key gene. This helps them adapt quickly and can lead to antibiotic resistance, which is a big problem worldwide. E. coli is a common gut bacterium that can cause urinary tract infections.

“The E. Coli bacteria can survive a broad-spectrum antibiotic called trimethoprim as it copies a gene called folA, which helps them resist the drug. This increases the amount of the protein the antibiotic targets and helps the bacteria grow even in the presence of the drug. These extra copies usually disappear, but they give the bacteria time to develop permanent resistance mutations,” Nishad Matange, assistant professor, DBT/Wellcome Trust India Alliance; intermediate fellow, Department of Biology, IISER, told The Indian Express.

In the study at IISER Pune (published in eLife, 2025, funded by DBT/Wellcome Trust India Alliance), Dr Nishad showed that bacteria use these temporary increases in gene copy number to survive antibiotic treatment.

“This may be one reason why antibiotic resistance is spreading so fast. Understanding this process could help slow down the evolution of drug resistance,” he said.

Most living organisms have two copies of each gene in their cells (diploid), but bacteria usually have only one copy (haploid). Interestingly, bacteria can temporarily increase the number of copies of certain genes, which helps them adapt quickly, especially to antibiotics.

The study also showed that a bacterial enzyme, Lon protease, controls how often these gene copy changes happen. Understanding this process could help improve strategies to detect and fight antibiotic-resistant bacteria.

Researchers also said it would be important to investigate how frequently these kinds of gene copy changes occur in clinical strains and whether they play a role as resistance evolves in patients undergoing treatment.

“Overall, our study shows that gene copy number changes play a key role in how bacteria become resistant to antibiotics. This knowledge could help develop better diagnostic tools and treatment strategies,” Dr Nishad added.

Related Posts

Zydus Lifesciences Q4FY26 net profit rises 9%

Zydus board approved a buyback of up to Rs 1100 crore at Rs 1,150 per share, along with a 100 percent dividend for FY26. Zydus Lifesciences reported a rise in…

Chemists strike on May 20: Reasons behind today’s all-India strike

While major pharmacy chains and government medical outlets will remain operational, the strike highlights significant tensions within the industry that could impact access to medications nationwide. The All India Organisation…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Zydus Lifesciences Q4FY26 net profit rises 9%

Zydus Lifesciences Q4FY26 net profit rises 9%

Chemists strike on May 20: Reasons behind today’s all-India strike

Chemists strike on May 20: Reasons behind today’s all-India strike

AbbVie loses patent plea for Hep C drug

AbbVie loses patent plea for Hep C drug

GSK’s Calpol a well-known trademark: High Court

GSK’s Calpol a well-known trademark: High Court

3 arrested for allegedly posing as doctors using forged MBBS degrees

3 arrested for allegedly posing as doctors using forged MBBS degrees

Commissioner FDA reviews enforcement measures

Commissioner FDA reviews enforcement measures